Executive director of the Trial Innovation Center at the University of Utah.
Director of the Institutional Review Board and Human Research Protection Program at the University of Utah.
Ethics Hum Res. 2022 Nov;44(6):32-38. doi: 10.1002/eahr.500149.
Since the 2016 National Institutes of Health (NIH) mandate to use a single IRB (sIRB) in multicenter research, institutions have struggled to operationalize the process. In this demonstration project, the University of Utah Trial Innovation Center assisted the Collaborative Pediatric Critical Care Research Network to transition from using individually negotiated reliance agreements and paper-based documentation to a new sIRB master agreement and an informatics platform to capture reliance documentation. Lessons learned that can guide other academic institutions and IRBs as they operationalize sIRBs included the need for sites to understand what type of engagement or reliance is required and their need to understand the difference between reliance and activation. Requirements around local review remain poorly understood. Further research is needed to determine approaches that can achieve the NIH vision of reviews becoming more efficient and improving study start-up times, relieving administrative burden while advancing human research protections.
自 2016 年美国国立卫生研究院(NIH)要求在多中心研究中使用单一的机构审查委员会(sIRB)以来,各机构一直在努力实施这一过程。在这个示范项目中,犹他大学试验创新中心协助儿科危重病研究网络合作组织从使用单独协商的依赖协议和基于纸张的文件过渡到使用新的 sIRB 主协议和一个信息学平台来捕获依赖文件。在实施 sIRB 方面,可以为其他学术机构和 IRB 提供指导的经验教训包括:需要站点了解需要哪种类型的参与或依赖,以及他们需要了解依赖和激活之间的区别。对于本地审查的要求仍然知之甚少。需要进一步研究确定能够实现 NIH 愿景的方法,即提高审查效率和缩短研究启动时间,减轻行政负担,同时推进人类研究保护。